The aim of this study was to investigate the diversity and composition of the intestinal microbiota of elderly subjects using a combination of culture-dependent techniques and 16S rRNA gene amplicon sequencing. The study was performed as part of the ELDERMET project, in which 368 faecal samples were assessed for viable numbers of Bifidobacterium spp., Lactobacillus spp. and Enterobacteriaceae on selective agar. However, the Bifidobacterium selective medium used also supported the growth of Clostridium perfringens, which appeared as distinct colonies and were subsequently characterized phenotypically and genotypically. All the isolates were confirmed as toxin biotype A producers. In addition, three isolates tested also had the genetic determinants for the b2 toxin. Of the 368 faecal samples assessed, C. perfringens was detected in 28 samples (7.6 %). Moreover, C. perfringens was observed in samples from subjects in all the residence locations assessed but was most prevalent in subjects from long-stay residential care, with 71.4 % of the samples (63.2 % of the subjects) being from this residence location, and with a shedding level in excess of 10 6 c.f.u. (g faeces) "1
INTRODUCTION
Although the composition of the intestinal microbiota can vary greatly among individuals, the dominant population in the adult intestinal microbiota has been shown to be relatively stable over time (Zoetendal et al., 1998) . However, it is known that ageing impacts on the composition of the gut microbiota (Biagi et al., 2010; Claesson et al., 2011) . illnesses caused by Clostridium perfringens enterotoxin (Sparks et al., 2001) .
The ELDERMET project (http://eldermet.ucc.ie) aims to elucidate the intestinal microbiota of 500 elderly (¢65 years) Irish subjects. Work to date has revealed a core gut microbiota rich in Bacteroidetes and Firmicutes with large inter-individual variability (n5161) (Claesson et al., 2011) and with a distinctive pattern when compared with the younger Irish population (Claesson et al., 2009 (Claesson et al., , 2010 . In parallel with the sequence-based methods, culture-dependent techniques have enumerated the levels of Bifidobacterium spp., Lactobacillus spp. and Enterobacteriaceae in the faecal samples (O'Sullivan et al., 2011 (O'Sullivan et al., , 2013 . The current study focused mainly on Bifidobacterium spp. and Lactobacillus spp. among other human intestinal microbiota because of their potential probiotic role (Turroni et al., 2008; Aureli et al., 2011) . In this respect, several selective media have been recommended previously for the isolation of Bifidobacterium spp. (Beerens, 1990; Nebra & Blanch, 1999; Rada & Petr, 2000; Mikkelsen et al., 2003; Simpson et al., 2004; Thitaram et al., 2005; Ferraris et al., 2010) from various sample types (dairy products, faeces, intestinal samples and animal feed). In this study, de Man, Rogosa and Sharpe (MRS) medium supplemented with L-cysteine hydrochloride and mupirocin, termed Bifidobacterium selective medium (BSM), was used. This medium has been used previously for the growth and enumeration of Bifidobacterium spp. from human faecal samples (RosbergCody et al., 2004; Wall et al., 2008) .
Whilst one aim of the ELDERMET project was to enumerate bifidobacteria from faecal samples of elderly subjects, the fortuitous isolation of the clinically significant C. perfringens at high levels from a subset of these elderly subjects motivated the current study. Culture-independent techniques were used to compare the microbiota of the C. perfringens-positive subjects and -negative subjects to determine whether the presence of C. perfringens had an impact on the intestinal microbiota as a whole.
METHODS
Subject recruitment and sample collection. Subjects aged ¢65 years were recruited and examined at ELDERMET clinics at two local hospitals (Cork University Hospital, Cork, Ireland, and St Finbarr's Hospital, Cork, Ireland), as outlined previously (Claesson et al., 2011) . Residence locations of the subjects were defined as longterm residential care (long-stay, .6 weeks), short-term rehabilitation centres (rehab, ,6 weeks), outpatient in day hospitals and community dwelling. A subset of these subjects was undergoing antibiotic therapy within the month prior to faecal sampling. All subjects were screened for the presence of C. difficile. Informed consent was obtained from all subjects or, in cases of cognitive impairment, from next of kin in accordance with the local Clinical Research Ethics Committee guidelines. This study was approved by the Clinical Research Ethics Committee of the Cork Teaching Hospitals. Faecal samples were collected from some subjects at two further time points [at month 3 (T3) and month 6 (T6)]. Stool samples were collected in a sterile container and stored at 5 uC until transported on ice packs to the laboratory. Storage time varied, with a mean time of 28 h. Technology, Waterford, Ireland) and Streptococcus agalactiae LMG 14694 were used in this study. Bifidobacterium spp. and Lactobacillus spp. were grown anaerobically at 37 uC for 24-48 h on MRS agar (Difco Laboratories) supplemented with 0.05 % (w/v) L-cysteine hydrochloride (Sigma Chemical). Where solid medium was required, 1.5 % (w/v) agar (Oxoid) was added. To encourage selectivity for Bifidobacterium spp. from the faecal samples, the medium was supplemented with 100 mg mupirocin ml 21 (Oxoid), as outlined previously (Rosberg-Cody et al., 2004; Wall et al., 2008) . The antifungal agent nystatin (50 U ml 21 ; Sigma) was also included. All Clostridium strains were grown anaerobically at 37 uC for 24-48 h in trypticase soy agar (Merck) containing 7 % sheep blood (TCS Biosciences). All other bacterial strains were cultivated in brain-heart infusion (BHI; Merck) medium and grown aerobically at 37 uC.
Isolation and enumeration of Bifidobacterium spp. and Lactobacillus spp. Total culturable Bifidobacterium spp. and Lactobacillus spp. were enumerated as outlined previously (O'Sullivan et al., 2011) . The agar plates were incubated anaerobically for 3 or 5 days at 37 uC for Bifidobacterium spp. or Lactobacillus spp., respectively. Bacterial counts were recorded as c.f.u. (g faeces) 21 and results expressed as log c.f.u. g
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.
Phenotypic characterization of putative C. perfringens isolates Fructose 6-phosphoketolase assay. The fructose 6-phosphoketolase assay was performed as described by Bibiloni et al. (2000) . B. breve NCIMB 8807 and Lactobacillus delbrueckii subsp. bulgaricus DPC 6901 were used as positive and negative controls, respectively. A positive reaction, which is typical of Bifidobacterium spp., resulted in the development of a red-violet colour.
Stormy clot assay. C. perfringens was inoculated at 1 % (v/v) into 10 ml reconstituted skimmed milk in a test tube, which was then plugged with 2 % agar and incubated at 37 uC overnight. Coagulation of the milk resulting in a stormy clot was indicative of C. perfringens (MacFaddin, 1976) .
Reverse CAMP test. C. perfringens cultures were streaked at right angles to within 1-2 mm of a b-haemolytic group B Streptococcus (S. agalactiae LMG 14694) on sheep blood agar plates. The agar plates were incubated anaerobically for 18-24 h. A positive reverse CAMP test was indicated by the formation of a bow-tie or reverse arrow pattern of haemolysis at the junction of the two cultures (Buchanan, 1982) .
Mupirocin resistance of C. perfringens. To assess the sensitivity of a selection of C. perfringens strains to mupirocin, the putative C. perfringens ELDERMET isolates and the C. perfringens strains from Alimentary Health Ltd (n510), together with C. perfringens NCTC 8239, C. perfringens WIT 495, C. perfringens LMG 10468 and C. perfringens LMG 11264 were streaked onto agar plates with increasing concentrations of mupirocin (100-500 mg ml 21 ). B. breve NCIMB 8807 and B. bifidum NCIMB 795 were used as positive controls, and
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Lactobacillus delbrueckii subsp. bulgaricus LMG 6901 and Listeria innocua DPC 3572 were used as negative controls.
Genotypic characterization
Isolation of genomic DNA. Genomic DNA was extracted as outlined previously (Coakley et al., 1996) . RNase (0.75 ml; Sigma) was added to the extracted DNA, incubated for 1 h at 37 uC and denatured at 65 uC for 15 min.
16S rRNA gene sequence analysis to identify bacterial isolates.
The full-length 16S rRNA gene was amplified from the genomic DNA of each strain using 16S rRNA gene eubacterial primers (Simpson et al., 2003) . The complete sequence of the 16S rRNA gene region was determined by Sanger sequencing (Beckman Coulter Genomics). The species was identified by nucleotide alignments (.98 % identity cutoff) with the sequences of species deposited in the GenBank and using the RDP Classifier (Wang et al., 2007) .
PFGE. Following overnight incubation, 200 ml each culture was inoculated into 10 ml BHI broth, which had previously been boiled and cooled under anaerobic conditions, and grown for 5 h at 37 uC. Genomic DNA was prepared in agarose plugs, lysed and subsequently digested with SmaI, as described by Lukinmaa et al. (2002) . Electrophoresis was performed using a Bio-Rad Chef-DR II instrument for 20 h at 5.5 V cm 21 with initial and final pulse times of 0.5 and 40 s, respectively. A l ladder pulsed-field gel marker (New England BioLabs) ranging from 48.5 to 727.5 kb was used as the molecular-mass marker, and DNA macrorestriction profiles were visualized using an Alpha Imaging system. The DNA banding patterns were analysed using Bionumerics software version 6.5 (Applied Maths). The Dice coefficient of similarity was calculated and UPGMA was used for cluster analysis with optimization and position tolerance set at 1.5 %. A cut-off at 90 % similarity of the Dice coefficient was used to indicate identical PFGE patterns.
Assessment of toxin production by C. perfringens isolates
Detection of the cpe enterotoxin gene. PCR was used to detect the presence of the cpe enterotoxin gene in the C. perfringens isolates as outlined by Lukinmaa et al. (2002) . C. perfringens NCTC 8239 was used as a positive control. The presence of the cpe enterotoxin gene was indicated by amplification of a 933 bp fragment.
Enterotoxin immunoassay. Prior to the enterotoxin test, all isolates were grown in modified Duncan-Strong sporulation medium (Duncan & Strong, 1968) to promote enterotoxin production. Enterotoxin production was assessed using a reverse passive latex agglutination kit (PET-RPLA kit; Oxoid).
Detection of other toxin genes. Primers corresponding to the a toxin (cpa), b toxin (cpb) or e toxin (etx) gene were used as described by Wu et al. (2009) to assess the C. perfringens isolates for toxin production capability. In addition, production of the b2 toxin, encoded by cpb2 gene, was assessed as outlined by Greco et al. (2005) .
Amplicon sequencing and bioinformatics. DNA was extracted from faecal samples according to a standard protocol (Qiagen). Pyrosequencing yielded a mean of 32 677 reads per sample. Amplicon sequencing analysis was performed as outlined previously (Claesson et al., 2011 ). Trimmed FASTA sequences were then RDP classified from phylum down to genus level (Wang et al., 2007 ) using Bergey's taxonomy (Garrity et al., 2004) . Species level data were generated using a combination of the Qiime package (http://qiime. org/) and BLAST. First, individual reads were grouped into operational taxonomic units (OTUs) at 97 % sequence similarity using UCLUST, and a representative sequence was then chosen from each OTU using the default method. These representative sequences were then analysed using BLAST against a custom-made species database to identify species from the genus Clostridium and any other species of interest. OTU assignment, clustering and correspondence analysis were implemented with Qiime. The data generated from BLAST and the RDP Classifier were stored in a MYSQL database.
Statistical methods. Statistical analysis for the bacteriological culture data was performed using Minitab Release version 15.1.1.0 (Minitab Inc.). Significance was calculated with a Mann-Whitney U test and statistical significance was accepted at P,0.05. The R statistical software version 2.13.1 was used for the amplicon sequencing statistical analyses. For each subject, all reads at phylum, family and genus level were converted to percentage values of the total number of reads. The Mann-Whitney U test was used to test for statistical differences between the C. perfringens-positive dataset (n527) and the C. perfringens-negative dataset (n5254) for each taxon in the phylum, family and genus level datasets. P values were adjusted to account for multiple testing. Two related methods were used: estimation of q values using the false discovery rate function in R for genus level, and Benjamini and Hochberg correction for phylum and family levels (Benjamini & Hochberg, 1995) .
RESULTS AND DISCUSSION
Prevalence of C. perfringens in the faecal microbiota of older subjects Of 368 faecal samples analysed (from 184 elderly subjects at T0, T3 and/or T6) during this study, 28 samples (7.6 % of samples from 19 subjects; Table 1 ) upon culture yielded colonies that were atypical of Bifidobacterium spp. on BSM. These atypical colonies were translucent, irregular-shaped (4-5 mm diameter), yellow colonies with a distinct odour, as opposed to the typical bifidobacterial colonies, which were white/cream, convex and circular in shape (2-3 mm diameter). From these 19 subjects, atypical colonies were observed at two time points for five subjects and at all three time points for two subjects, indicating the stability of the presence of this bacterium over time in the intestinal environment of some subjects. In some cases (n515), these isolates grew on the selective medium in conjunction with the Bifidobacterium spp., but in other cases (n513) only these unusual colonies were observed. However, they were reliably distinguishable from bifidobacteria both macroscopically and microscopically (larger boxcar-shaped rods). Moreover, these isolates tested negative in a fructose-6-phosphate phosphoketolase assay (a positive result is indicative of Bifidobacterium spp.), demonstrating that they were not bifidobacteria.
Phenotypic and genotypic characterization of C. perfringens
Approximately three to four colonies per sample were taken for further characterization. All of the atypical isolates demonstrated phenotypic traits characteristic of C. perfringens, such as stormy clot formation when grown in 10 % skimmed milk and an arrowhead-shaped haemolytic pattern in the reverse CAMP test. All isolates were subsequently confirmed as C. perfringens using 16S rRNA sequencing. C. perfringens isolates that have the potential to , C. difficile detected in the faecal sample. dOn antibiotics within 1 month of attending the ELDERMET clinic. §,3.00 indicates the lower limit of detection.
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Journal of Medical Microbiology 62 cause C. perfringens-associated diarrhoea, by the production of an enterotoxin, are normally identified by confirming the presence of the cpe gene. However, none of the isolates from this study was positive for the cpe gene, indicating that all were non-enterotoxigenic. This was further confirmed by testing all the isolates for enterotoxin production using an RPLA kit, which demonstrated that none produced enterotoxin. It has been reported that CPE enterotoxin-producing C. perfringens are only isolated occasionally, representing ,5 % of all C. perfringens isolates (Smedley & McClane, 2004) .
Genotyping of the toxin produced by C. perfringens
In general, all C. perfringens types produce a toxin; additionally, type B C. perfringens produce b and e toxins, type C produce b toxin, type D produce e toxin and type E produce i toxin (Petit et al., 1999) . Type A C. perfringens has been shown to predominate in the environment and can cause gas gangrene in humans, whilst the other types (B-E) are usually restricted to animals. As type E strains rarely cause disease in humans (Petit et al., 1999; Smedley & McClane 2004) , none of the C. perfringens isolates from this study was tested for this toxin. The cpa gene, encoding a toxin, was detected by PCR in all of the isolates, but none of the other genes, including the cpb gene (encoding b toxin in types B and C) or the etx gene (encoding e toxin in types B and D), was detected. This confirmed that all the isolates belonged to C. perfringens type A. In addition to the a toxin, three of the isolates (EM156-T6, EM177-T0 and EM200-T6) produced b2 toxin and were then classified as C. perfringens type A and b2 toxin positive. PCR and sequence analysis revealed 100 % amino acid identity with the cpb2 structural gene of the characterized b2 toxin (Shimizu et al., 2002) , indicating the presence of this toxin in all three isolates. Although b2 toxin-positive C. perfringens have been linked with intestinal disorders in animals (Waters et al., 2003) and humans (Fisher et al., 2005) , their presence does not always result in an adverse effect on the intestine (Lebrun et al., 2007; Carman et al., 2008) . In this respect, the impact of the b2 toxin appears to be subject dependent and circumstance related.
Relatedness and stability of C. perfringens isolates
Genomic fingerprinting by PFGE is a valuable tool when establishing strain similarities and has been used for strain identification in C. perfringens-related diarrhoeal outbreak situations (Lukinmaa et al., 2002) . Diversity among the C. perfringens isolates from this study was observed, as they were resolved into 17 distinct strains (A-Q) using the Dice coefficient (¢90 % similarity). This diversity is noteworthy, as these strains were isolated from 19 C. perfringens-positive subjects residing in different residence locations.
The C. perfringens PFGE profiles from four subjects (EM156-T0, EM165-T0, EM168-T3 and EM169-T0) were confirmed as being 100 % identical (Fig. 1) . Although these subjects were sampled over a 9-month period, all were from the same residence location (long-term residential care) and even the same ward. Similarly, the profiles from subjects EM186-T0 and EM200-T0 were 100 % identical (Fig. 1) . Interestingly, at the time of sampling, these subjects were residing on the same ward and were sampled within 15 days of each other. 
Detection of Clostridium perfringens in the elderly
In some cases, the persistence of the C. perfringens strains was confirmed by isolating similar pulsotypes from the same subject at multiple time points, as recorded for EM082 (T3 and T6), EM151 (T0, T3 and T6), EM156 (T0 and T6), EM168 (T3 and T6) and in EM182 (T3 and T6), indicating their stability of colonization over time. However, diversity among the strains was observed over time in a few subjects. For instance, the faecal samples collected at all three time points for EM159 showed strains with two distinct PFGE patterns (one at T0 and another at each of T3 and T6). In EM200, where two distinct strains of C. perfringens were observed at T0 and T6 (Fig. 1) , C. perfringens was not detected at the intermediate time (T3). This subject was on the same ward at all time points but was receiving antibiotics at T0 and T6, the time points where C. perfringens was detected. Overall, the PFGE analysis revealed a diverse range of pulsotypes from the different residence locations.
Mupirocin resistance of C. perfringens isolates and co-association with bifidobacteria
In general, supplementation of selective media with mupirocin enables the recovery of Bifidobacterium spp. from faecal samples. However, in this study, C. perfringens was isolated on BSM, despite using a high concentration of mupirocin (100 mg ml
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). The growth of these isolates on this selective medium was reasonably distinguishable, both macroscopically and microscopically. To assess the resistance of C. perfringens in general to mupirocin, a number of strains comprising C. perfringens NCTC 8239, C. perfringens LMG 10468, C. perfringens LMG 11264, a selection of C. perfringens strains (n510) and C. perfringens WIT 495 were grown on agar plates with varying concentrations of mupirocin (Table 2 ). All the C. perfringens isolates assessed grew at all mupirocin concentrations up to 500 mg ml
, indicating a high level of resistance. This high level of mupirocin resistance may provide an opportunity to exploit the antibiotic as a selective agent for C. perfringens. However, this study does indicate the limitations of using mupirocin as a selective agent for Bifidobacterium spp.
During the broader ELDERMET study, BSM has been used to enumerate Bifidobacterium spp. from 366 faecal samples (O'Sullivan et al., 2013) . The levels of Bifidobacterium spp. were below the limit of detection (,3.0 log c.f.u. g 21 ) in 5.2 % of these faecal samples. When analysing the samples where C. perfringens was detected on BSM (n528), Bifidobacterium spp. were below the limit of detection for 46.0 % of these samples. This indicates that the presence of C. perfringens in the elderly is inversely associated with the Fig. 2 . Family-level composition of the faecal microbiota from C. perfringens-positive subjects (aggregated) (a) and the C. perfringens-negative subjects (aggregated) (b).
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numbers of Bifidobacterium spp. recovered. In addition, when the levels of culturable Bifidobacterium spp. and Lactobacillus spp. were compared in the C. perfringenspositive and -negative groups, significantly lower levels (P,0.05) of both species were observed in the C. perfringens-positive group.
Prevalence of C. perfringens as a function of subject health status C. perfringens was detected in subjects from all of the residence locations assessed (long-stay, rehabilitation, day hospital and community) and at varying levels [4.0-9.5 log c.f.u. (g faeces)
21
; Table 1 ]. However, the long-stay subjects accounted for 71.4 % of the samples where C. perfringens was detected. This is in agreement with the study by Stringer et al. (1985) , reporting high numbers of C. perfringens in elderly hospitalized patients (Yamagishi et al., 1976; Stringer et al., 1985) . It has also been reported that the carriage rate of C. perfringens is significantly higher in the elderly (Benno et al., 1989) . C. perfringens type A food poisoning outbreaks are usually reported in institutionalized settings involving larger numbers of elderly patients (Smith, 1998; Lund et al., 2000) .
Microbiota alterations and C. perfringens culture status
Microbiota composition analysis by amplicon sequencing was used to determine whether the presence of C. perfringens was associated with an altered intestinal microbiota. Pyrosequencing data were available for 27 C. perfringens-positive samples and 254 C. perfringens-negative samples. The taxonomical profile of each sample was elucidated using a combination of BLAST and RDP Classifier, and the resulting taxa were compared at the phylum, family and genus levels. Whilst there were some observed differences at the phylum level, none of these was statistically significant. The major observed differences were Bacteroidetes and Proteobacteria proportions of 52.2 and 2.7 %, respectively, in the C. perfringens-negative dataset compared with 48.4 and 1.5 % in the C. perfringens-positive dataset, whilst Firmicutes were higher at 44.0 % in the negative population compared with 48.6 % in the positive population. At the family level, some significant changes in compositional data were observed. Members of the families Clostridiaceae (P50.0003), Eubacteriaceae (P50.0033), Coriobacteriaceae (P50.0103), Enterobacteriaceae (P50.0337), Desulfovibrionaceae (P5 0.0374) and Porphyromonadaceae (P50.0383) were higher in the C. perfringens-positive dataset compared with the negative dataset. Members of the families Lachnospiraceae (P50.0011) and Veillonellaceae (P50.0383) were lower in the C. perfringens-positive subject microbiota when compared with the negative subjects ( Fig. 2 and Table 3 ).
There were many significant differences in the proportions of individual genera between the C. perfringens-positive and -negative datasets; ten genera appeared to be higher in the C. perfringens-positive population including Clostridium spp. (P,0.0001), Eubacterium (P50.0022) and Parabacteroides (P50.0084). In contrast, Coprococcus (P5 0.0233), Roseburia (P50.0006), Catenibacterium (P5 0.0363) and Bifidobacterium (P50.0363) were lower in the positive group (Fig. 3 and Table 3 ).
Levels of Bifidobacterium spp. were significantly lower in the C. perfringens-positive population (P50.0363; Table 3 ), which is in agreement with the culture-based techniques as discussed above. In contrast to the culture results, no significant difference was observed in levels of Lactobacillus spp. (P50.9375). To establish the similarities in the total microbial composition between the C. perfringens-positive and -negative samples, correspondence analysis on the proportions at phylum, family and genus level was employed. This failed to show any major differences in Table 3 . Significant differences in faecal microbiota abundance between the C. perfringens-positive and -negative subjects
Only taxa with significant differences are shown. Detection of Clostridium perfringens in the elderly the microbiota composition between these two groups ( Supplementary Fig. S1 , available with the online version of this paper).
In conclusion, this study focused on the isolation of high levels of C. perfringens from faecal samples of elderly Irish subjects, on a selective medium aimed at isolating Bifidobacterium spp. The subjects were from different residence locations, with the isolation of C. perfringens being more frequent in subjects in long-stay care and having a higher shedding level [up to 10 9 c.f.u. (g faeces)
21
]. The isolation of similar C. perfringens strains from individual subjects located in the same residence location suggested horizontal transmission within the hospital. The presence of C. perfringens negatively correlated with the number of Bifidobacterium spp. recovered, suggesting that Bifidobacterium spp. replacement warrants investigation as a possible means of reducing C. perfringens carriage. However, overall, there was no significant diversity among the microbial community between the C. perfringens-positive and -negative subjects.
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